Last-resort virus therapy takes on untreatable hip infection

NCT ID NCT07461337

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether specially designed viruses (bacteriophages) can eliminate a persistent bacterial infection in a hip replacement joint. One adult who has failed all standard surgeries and antibiotics will receive the viruses directly into the joint and through an IV for two weeks. The goal is to clear the infection and avoid further complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIOPHAGE THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Foothills Medical Centre, University of Calgary

    Calgary, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.